Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial.
Br J Clin Pharmacol January 17, 2024 Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag et al. 7 citations
Lingering long COVID symptoms often severely impact daily life. A trial explored if a cannabidiol-dominant product offers a viable treatment. Participants experienced encouraging improvements in issues like pain, sleep, fatigue, and anxiety. This suggests a promising way to alleviate these symptoms and significantly boost overall quality of life for those affected by long COVID.